Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

SABCS 2016

Videos
News
A phase III study of buparlisib and fulvestrant in HR positive advanced breast...
Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016
Five years of letrozole does not improve disease free survival for pretreated...
Dr Terry Mamounas - UF Health Center, Orlando, USA
Five years of letrozole does not improve disease free survival for pretreated HR positive breast cancer ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
14 Dec 2016
Reducing chemo-associated hair loss with scalp cooling cap
Dr Julie Rani Nangia - Baylor College of Medicine, Houston, USA
Reducing chemo-associated hair loss with scalp cooling cap ( Dr Julie Rani Nangia - Baylor College of Medicine, Houston, USA )
14 Dec 2016
Decoding breast cancer predisposition genes
Dr Fergus Couch - Mayo Clinic, Rochester, USA
Decoding breast cancer predisposition genes ( Dr Fergus Couch - Mayo Clinic, Rochester, USA )
14 Dec 2016
Macrophage iron recycling in triple negative breast cancer
Dr Lisa Privette Vinnedge - Cincinnati Children's Hospital, Cincinnati, USA
Macrophage iron recycling in triple negative breast cancer ( Dr Lisa Privette Vinnedge - Cincinnati Children's Hospital, Cincinnati, USA )
14 Dec 2016
Results of the BELLE-3 study of buparlisib for advanced breast cancer
Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
Results of the BELLE-3 study of buparlisib for advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016
Epirubicin and cyclophosphamide before docetaxel in early breast cancer
Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark
Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )
14 Dec 2016
Matched mutations and long term letrozole for breast cancer
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA
Matched mutations and long term letrozole for breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA )
14 Dec 2016
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
13 Dec 2016
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer
Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
13 Dec 2016
No benefit for adjuvant ibandronate at 3 years in early breast cancer
Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
No benefit for adjuvant ibandronate at 3 years in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
13 Dec 2016
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer
Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
13 Dec 2016
Matched mutations in the progression of metastatic breast cancer
Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA
Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )
13 Dec 2016
Expert discussion on CDK 4/6 inhibition in breast cancer
Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain
Expert discussion on CDK 4/6 inhibition in breast cancer ( Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain )
12 Dec 2016
PD-1 therapy with eribulin for triple negative MBC
Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA
PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )
9 Dec 2016
Women experiencing menopause symptoms less likely to adhere to medication
Dr Samuel Smith - University of Leeds, Leeds, UK
Women experiencing menopause symptoms less likely to adhere to medication ( Dr Samuel Smith - University of Leeds, Leeds, UK )
9 Dec 2016
Breast cancer mortality declining globally
Dr Cécile Pizot - International Prevention Research Institute, Lyon, France
Breast cancer mortality declining globally ( Dr Cécile Pizot - International Prevention Research Institute, Lyon, France )
9 Dec 2016
Everolimus extends PFS for HR positive, HER2 negative breast cancer
Dr Noah Kornblum - Montefiore Medical Center, New York, USA
Everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )
9 Dec 2016
TEAM IIb trial results: Adjuvant ibandronate in early breast cancer
Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
TEAM IIb trial results: Adjuvant ibandronate in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
9 Dec 2016
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Dec 2016
TCHP with/out oestrogen for HR/HER positive breast cancer
Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
TCHP with/out oestrogen for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
8 Dec 2016
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in...
Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
7 Dec 2016
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Dr Terry Mamounas - UF Health Center, Orlando, USA
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
7 Dec 2016
Whole exome and transcriptome sequencing of resistant ER positive metastatic...
Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )
7 Dec 2016
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast...
Dr Noah Kornblum - Montefiore Medical Center, New York, USA
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )
7 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation